Grünenthal
Grünenthal is a German pharmaceutical company founded in 1946 in Aachen. In OnCo it is the marketing authorisation holder of PecFent, a fentanyl nasal spray authorised in the EU for breakthrough pain in adults on maintenance opioids for chronic cancer pain.
Overview
Grünenthal GmbH is a German pharmaceutical company based in Aachen, founded on 29 January 1946 (Wikidata Q153838, which also gives its website and English Wikipedia article). The EMA register names Gruenenthal GmbH as the marketing authorisation holder of PecFent (fentanyl pectin nasal spray), authorised 31 August 2010 for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. It sponsors no trial recorded in OnCo.
Scorecard
All companies- approved products +6
- targets +2
- modalities +2
- regions +1
These are fast-acting forms of the opioid fentanyl, taken as a tablet against the cheek or as a nasal spray, for sudden flares of pain in people whose cancer pain is otherwise controlled by a regular opioid. They are only for patients already tolerant to opioids.